Laili Kharazi Boozary1, Summer G Frank-Pearce2, Adam C Alexander3, Joseph J C Waring4, Sarah J Ehlke4, Michael S Businelle3, Amy M Cohn5, Darla E Kendzor6. 1. Department of Psychology, Cellular and Behavioral Neurobiology, The University of Oklahoma, Norman, OK, United States; TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. 2. Department of Biostatistics and Epidemiology, Hudson College of Public Health, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. 3. Department of Family and Preventive Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. 4. TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. 5. TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Department of Pediatrics, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. 6. Department of Family and Preventive Medicine, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; TSET Health Promotion Research Center, Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States. Electronic address: Darla-Kendzor@ouhsc.edu.
Abstract
BACKGROUND: Little is known about the correlates of e-cigarette (EC) use among adults seeking smoking cessation treatment, and it is unclear how EC use affects smoking treatment outcomes. METHODS: Participants were 649 adult smokers enrolled in smoking cessation treatment. Participants completed a baseline (pre-quit) assessment with follow-up at 4-, 12-, and 26-weeks after a scheduled combustible cigarette (CC) cessation date. EC use was described before and after the CC cessation date, and the impact of baseline EC use on CC cessation at follow-up was evaluated. RESULTS: At baseline, 66.6 % of participants had ever-used ECs and 23.1 % reported past 30-day EC use. Past 30-day EC users were younger, more socioeconomically disadvantaged, more CC dependent, and less likely to report Black race compared to non-users. At the 4-, 12-, and 26-week follow-ups, 6.4 %, 7.4 %, and 8.1 % reported dual EC/CC use; and 2.7 %, 3.4 %, and 2.7 % had switched to exclusive EC use. Past 30-day EC use at baseline was not associated with CC cessation at any follow-up. However, among baseline past 30-day EC users (n = 150), using ECs ≥ once per week was associated with a lower likelihood of CC cessation at 26-week follow-up (adjusted OR 0.346, 95 % CI: 0.120, 0.997). CONCLUSION: Findings indicated that dual users of CCs and ECs at baseline differed from CC-only users on sociodemographic and smoking characteristics. Baseline EC use did not impact smoking cessation overall. However, among past 30-day users, more frequent EC use at baseline adversely impacted longer-term cessation outcomes, perhaps due to greater baseline CC/nicotine dependence.
BACKGROUND: Little is known about the correlates of e-cigarette (EC) use among adults seeking smoking cessation treatment, and it is unclear how EC use affects smoking treatment outcomes. METHODS: Participants were 649 adult smokers enrolled in smoking cessation treatment. Participants completed a baseline (pre-quit) assessment with follow-up at 4-, 12-, and 26-weeks after a scheduled combustible cigarette (CC) cessation date. EC use was described before and after the CC cessation date, and the impact of baseline EC use on CC cessation at follow-up was evaluated. RESULTS: At baseline, 66.6 % of participants had ever-used ECs and 23.1 % reported past 30-day EC use. Past 30-day EC users were younger, more socioeconomically disadvantaged, more CC dependent, and less likely to report Black race compared to non-users. At the 4-, 12-, and 26-week follow-ups, 6.4 %, 7.4 %, and 8.1 % reported dual EC/CC use; and 2.7 %, 3.4 %, and 2.7 % had switched to exclusive EC use. Past 30-day EC use at baseline was not associated with CC cessation at any follow-up. However, among baseline past 30-day EC users (n = 150), using ECs ≥ once per week was associated with a lower likelihood of CC cessation at 26-week follow-up (adjusted OR 0.346, 95 % CI: 0.120, 0.997). CONCLUSION: Findings indicated that dual users of CCs and ECs at baseline differed from CC-only users on sociodemographic and smoking characteristics. Baseline EC use did not impact smoking cessation overall. However, among past 30-day users, more frequent EC use at baseline adversely impacted longer-term cessation outcomes, perhaps due to greater baseline CC/nicotine dependence.
Authors: Alana M Rojewski; Nichole T Tanner; Lin Dai; James G Ravenel; Mulugeta Gebregziabher; Gerard A Silvestri; Benjamin A Toll Journal: Chest Date: 2018-05-21 Impact factor: 9.410
Authors: Neal L Benowitz; John T Bernert; Jonathan Foulds; Stephen S Hecht; Peyton Jacob; Martin J Jarvis; Anne Joseph; Cheryl Oncken; Megan E Piper Journal: Nicotine Tob Res Date: 2020-06-12 Impact factor: 4.244
Authors: David B Abrams; Allison M Glasser; Jennifer L Pearson; Andrea C Villanti; Lauren K Collins; Raymond S Niaura Journal: Annu Rev Public Health Date: 2018-01-11 Impact factor: 21.981
Authors: Maciej Lukasz Goniewicz; Jakub Knysak; Michal Gawron; Leon Kosmider; Andrzej Sobczak; Jolanta Kurek; Adam Prokopowicz; Magdalena Jablonska-Czapla; Czeslawa Rosik-Dulewska; Christopher Havel; Peyton Jacob; Neal Benowitz Journal: Tob Control Date: 2013-03-06 Impact factor: 7.552
Authors: David J Nutt; Lawrence D Phillips; David Balfour; H Valerie Curran; Martin Dockrell; Jonathan Foulds; Karl Fagerstrom; Kgosi Letlape; Anders Milton; Riccardo Polosa; John Ramsey; David Sweanor Journal: Eur Addict Res Date: 2014-04-03 Impact factor: 3.015
Authors: MeLisa R Creamer; Teresa W Wang; Stephen Babb; Karen A Cullen; Hannah Day; Gordon Willis; Ahmed Jamal; Linda Neff Journal: MMWR Morb Mortal Wkly Rep Date: 2019-11-15 Impact factor: 17.586
Authors: Darla E Kendzor; Michael S Businelle; Damon J Vidrine; Summer G Frank-Pearce; Ya-Chen Tina Shih; Jesse Dallery; Adam C Alexander; Laili Kharazi Boozary; Joseph J C Waring; Sarah J Ehlke Journal: Contemp Clin Trials Date: 2022-01-31 Impact factor: 2.261
Authors: John P Pierce; Ruifeng Chen; Sheila Kealey; Eric C Leas; Martha M White; Matthew D Stone; Sara B McMenamin; Dennis R Trinidad; David R Strong; Tarik Benmarhnia; Karen Messer Journal: JAMA Netw Open Date: 2021-10-01